Resource use and costs in a Swedish cohort of patients with Parkinson's disease
Identifieur interne : 000524 ( Istex/Curation ); précédent : 000523; suivant : 000525Resource use and costs in a Swedish cohort of patients with Parkinson's disease
Auteurs : Peter Hagell [Suède] ; Sara Nordling [Suède] ; Jan Reimer [Suède] ; Martin Grabowski [Suède] ; Ulf Persson [Suède]Source :
- Movement Disorders [ 0885-3185 ] ; 2002-11.
English descriptors
- KwdEn :
Abstract
We estimated resource use and costs in patients with Parkinson's disease (PD), thereby providing baseline data for future economic evaluations of therapeutic interventions. Data were collected from medical records of a South Swedish cohort of 127 PD patients during 1 year (1996) and a mailed questionnaire inquiring about cost‐related consequences and resource use in 1996 and in 2000. Annual costs were calculated based on prevalence and expressed in SEK (monetary value of the year 2000). Direct health care costs averaged approximately SEK 29,000 (≈USD 2,900; EUR 3,200) per patient per year, of which drugs were the most costly component. Nonmedical direct costs were higher than direct health care costs, averaging approximately SEK 43,000 (≈USD 4,300; EUR 4,800) per patient per year, and costs due to lost production were approximately SEK 52,000 (≈USD 5,200; EUR 5,800) per patient per year. The mean total annual cost for PD in our sample approximated SEK 124,000 (≈USD 12,400; EUR 13,800) per patient. These findings are roughly within the same range as estimates from other countries and show that PD causes a considerable societal burden. In addition to other outcomes, evaluations of the economic implications of new therapeutic interventions are highly warranted. In this perspective, the present study provides valuable baseline data. © 2002 Movement Disorder Society
Url:
DOI: 10.1002/mds.10262
Links toward previous steps (curation, corpus...)
- to stream Istex, to step Corpus: Pour aller vers cette notice dans l'étape Curation :000524
Links to Exploration step
ISTEX:969B478B47668E4DC75C4B00EE08C994A1A045A1Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Resource use and costs in a Swedish cohort of patients with Parkinson's disease</title><author><name sortKey="Hagell, Peter" sort="Hagell, Peter" uniqKey="Hagell P" first="Peter" last="Hagell">Peter Hagell</name><affiliation wicri:level="1"><mods:affiliation>Section of Restorative Neurology, Department of Clinical Neuroscience, University Hospital, Lund, Sweden</mods:affiliation><country xml:lang="fr">Suède</country><wicri:regionArea>Section of Restorative Neurology, Department of Clinical Neuroscience, University Hospital, Lund</wicri:regionArea></affiliation><affiliation wicri:level="1"><mods:affiliation>Division of Neurology, Department of Clinical Neuroscience, University Hospital, Lund, Sweden</mods:affiliation><country xml:lang="fr">Suède</country><wicri:regionArea>Division of Neurology, Department of Clinical Neuroscience, University Hospital, Lund</wicri:regionArea></affiliation></author><author><name sortKey="Nordling, Sara" sort="Nordling, Sara" uniqKey="Nordling S" first="Sara" last="Nordling">Sara Nordling</name><affiliation wicri:level="1"><mods:affiliation>Swedish Institute for Health Economics, Lund, Sweden</mods:affiliation><country xml:lang="fr">Suède</country><wicri:regionArea>Swedish Institute for Health Economics, Lund</wicri:regionArea></affiliation></author><author><name sortKey="Reimer, Jan" sort="Reimer, Jan" uniqKey="Reimer J" first="Jan" last="Reimer">Jan Reimer</name><affiliation wicri:level="1"><mods:affiliation>Division of Neurology, Department of Clinical Neuroscience, University Hospital, Lund, Sweden</mods:affiliation><country xml:lang="fr">Suède</country><wicri:regionArea>Division of Neurology, Department of Clinical Neuroscience, University Hospital, Lund</wicri:regionArea></affiliation></author><author><name sortKey="Grabowski, Martin" sort="Grabowski, Martin" uniqKey="Grabowski M" first="Martin" last="Grabowski">Martin Grabowski</name><affiliation wicri:level="1"><mods:affiliation>Division of Neurology, Department of Clinical Neuroscience, University Hospital, Lund, Sweden</mods:affiliation><country xml:lang="fr">Suède</country><wicri:regionArea>Division of Neurology, Department of Clinical Neuroscience, University Hospital, Lund</wicri:regionArea></affiliation></author><author><name sortKey="Persson, Ulf" sort="Persson, Ulf" uniqKey="Persson U" first="Ulf" last="Persson">Ulf Persson</name><affiliation wicri:level="1"><mods:affiliation>Swedish Institute for Health Economics, Lund, Sweden</mods:affiliation><country xml:lang="fr">Suède</country><wicri:regionArea>Swedish Institute for Health Economics, Lund</wicri:regionArea></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:969B478B47668E4DC75C4B00EE08C994A1A045A1</idno><date when="2002" year="2002">2002</date><idno type="doi">10.1002/mds.10262</idno><idno type="url">https://api.istex.fr/document/969B478B47668E4DC75C4B00EE08C994A1A045A1/fulltext/pdf</idno><idno type="wicri:Area/Istex/Corpus">000524</idno><idno type="wicri:Area/Istex/Curation">000524</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Resource use and costs in a Swedish cohort of patients with Parkinson's disease</title><author><name sortKey="Hagell, Peter" sort="Hagell, Peter" uniqKey="Hagell P" first="Peter" last="Hagell">Peter Hagell</name><affiliation wicri:level="1"><mods:affiliation>Section of Restorative Neurology, Department of Clinical Neuroscience, University Hospital, Lund, Sweden</mods:affiliation><country xml:lang="fr">Suède</country><wicri:regionArea>Section of Restorative Neurology, Department of Clinical Neuroscience, University Hospital, Lund</wicri:regionArea></affiliation><affiliation wicri:level="1"><mods:affiliation>Division of Neurology, Department of Clinical Neuroscience, University Hospital, Lund, Sweden</mods:affiliation><country xml:lang="fr">Suède</country><wicri:regionArea>Division of Neurology, Department of Clinical Neuroscience, University Hospital, Lund</wicri:regionArea></affiliation></author><author><name sortKey="Nordling, Sara" sort="Nordling, Sara" uniqKey="Nordling S" first="Sara" last="Nordling">Sara Nordling</name><affiliation wicri:level="1"><mods:affiliation>Swedish Institute for Health Economics, Lund, Sweden</mods:affiliation><country xml:lang="fr">Suède</country><wicri:regionArea>Swedish Institute for Health Economics, Lund</wicri:regionArea></affiliation></author><author><name sortKey="Reimer, Jan" sort="Reimer, Jan" uniqKey="Reimer J" first="Jan" last="Reimer">Jan Reimer</name><affiliation wicri:level="1"><mods:affiliation>Division of Neurology, Department of Clinical Neuroscience, University Hospital, Lund, Sweden</mods:affiliation><country xml:lang="fr">Suède</country><wicri:regionArea>Division of Neurology, Department of Clinical Neuroscience, University Hospital, Lund</wicri:regionArea></affiliation></author><author><name sortKey="Grabowski, Martin" sort="Grabowski, Martin" uniqKey="Grabowski M" first="Martin" last="Grabowski">Martin Grabowski</name><affiliation wicri:level="1"><mods:affiliation>Division of Neurology, Department of Clinical Neuroscience, University Hospital, Lund, Sweden</mods:affiliation><country xml:lang="fr">Suède</country><wicri:regionArea>Division of Neurology, Department of Clinical Neuroscience, University Hospital, Lund</wicri:regionArea></affiliation></author><author><name sortKey="Persson, Ulf" sort="Persson, Ulf" uniqKey="Persson U" first="Ulf" last="Persson">Ulf Persson</name><affiliation wicri:level="1"><mods:affiliation>Swedish Institute for Health Economics, Lund, Sweden</mods:affiliation><country xml:lang="fr">Suède</country><wicri:regionArea>Swedish Institute for Health Economics, Lund</wicri:regionArea></affiliation></author></analytic><monogr></monogr><series><title level="j">Movement Disorders</title><title level="j" type="sub">Official Journal of the Movement Disorder Society</title><title level="j" type="abbrev">Mov. Disord.</title><idno type="ISSN">0885-3185</idno><idno type="eISSN">1531-8257</idno><imprint><publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher><pubPlace>New York</pubPlace><date type="published" when="2002-11">2002-11</date><biblScope unit="vol">17</biblScope><biblScope unit="issue">6</biblScope><biblScope unit="page" from="1213">1213</biblScope><biblScope unit="page" to="1220">1220</biblScope></imprint><idno type="ISSN">0885-3185</idno></series><idno type="istex">969B478B47668E4DC75C4B00EE08C994A1A045A1</idno><idno type="DOI">10.1002/mds.10262</idno><idno type="ArticleID">MDS10262</idno></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">0885-3185</idno></seriesStmt></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Parkinson's disease</term><term>costs</term><term>resource use</term></keywords></textClass><langUsage><language ident="en">en</language></langUsage></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">We estimated resource use and costs in patients with Parkinson's disease (PD), thereby providing baseline data for future economic evaluations of therapeutic interventions. Data were collected from medical records of a South Swedish cohort of 127 PD patients during 1 year (1996) and a mailed questionnaire inquiring about cost‐related consequences and resource use in 1996 and in 2000. Annual costs were calculated based on prevalence and expressed in SEK (monetary value of the year 2000). Direct health care costs averaged approximately SEK 29,000 (≈USD 2,900; EUR 3,200) per patient per year, of which drugs were the most costly component. Nonmedical direct costs were higher than direct health care costs, averaging approximately SEK 43,000 (≈USD 4,300; EUR 4,800) per patient per year, and costs due to lost production were approximately SEK 52,000 (≈USD 5,200; EUR 5,800) per patient per year. The mean total annual cost for PD in our sample approximated SEK 124,000 (≈USD 12,400; EUR 13,800) per patient. These findings are roughly within the same range as estimates from other countries and show that PD causes a considerable societal burden. In addition to other outcomes, evaluations of the economic implications of new therapeutic interventions are highly warranted. In this perspective, the present study provides valuable baseline data. © 2002 Movement Disorder Society</div></front></TEI></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Istex/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000524 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Istex/Curation/biblio.hfd -nk 000524 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Santé
|area= MovDisordV3
|flux= Istex
|étape= Curation
|type= RBID
|clé= ISTEX:969B478B47668E4DC75C4B00EE08C994A1A045A1
|texte= Resource use and costs in a Swedish cohort of patients with Parkinson's disease
}}
| This area was generated with Dilib version V0.6.23. |  |